THE EFFICACY OF COMBINATION THERAPY WITH LENALIDOMIDE AND DEXAMETHASONE IN THE TREATMENT OF RELAPSED MULTIPLE MYELOMA
Journal Title: Health Problems of Civilization - Year 2015, Vol 9, Issue 2
Abstract
Multiple myeloma is a neoplastic disease which is characterised by proliferation of monoclonal plasmocytes in the bone marrow. It is the second most common hematologic cancer and it represents 1% of all cancer deaths. Despite enormous development in multiple myeloma biology and treatment over the last 30 years - it is still incurable disease with a median survival of 50 — SS months. Currently, one of the most important goals in the treatment of multiple myeloma is to achieve long-term control of the disease, without negative impact on the patient's quality of life. Thanks to therapeutic regimens based on new immunomodulatory drugs, this aim seems to be achievable. In this paper we present the case of a female patient living with multiple myeloma for 14 years. Initially patient was treated with standard VAD [vincristine, doxorubicin, dexamethasone] chemotherapy regimen. After a nearly complete remission of the disease, autotransplantation of hematopoietic cells was performed. One year after transplantation there was a relapse of the disease. In the treatment of relapse it was decided to use scheme based on lenalidomide and dexamethasone. After 4“‘ cycle of treatment, a complete remission was achieved. So far, the patient received 149 cycles. In the evaluation of minimal residual disease still maintains a state of complete remission maintains. During over 12 years of treatment no complications in grade 3 and 4 of the CTCAE v.4 was observed. Currently the patient is 58 years old, she still receives lenalidomide and leads moderately active life.
Authors and Affiliations
Aneta Szudy-Szczyrek, Wojciech Legieć, Joanna Manko, Katarzyna Gmyz, Michal Szczyrek, Marek Hus
Keywords
Related Articles
- EP ID EP218936
- DOI 10.5114/hpc.2015.57115
- Views 81
- Downloads 0
VARIABLES DIFFERENTIATING POSITIVE HEALTH PROFILES AND SURVIVAL ABILITIES AMONG UKRAINIAN STUDENTS ATTENDING POST-SECONDARY MEDICAL SCHOOL
Background. Contemporary studies of health and evaluation attempts emphasize the holistic approach to health and its dimensions. The objective of the study was determination of health profiles and survival abilities amon...
FEATURES OF PHARMACOTHERAPY OF HEPATIC ENCEPHALOPATHY MANIFESTATIONS IN LIVER CIRRHOSIS
The aim of this work is to study the effect of drug mebikaron the clinical manifestations of hepatic encephalopathy in patients with liver cirrhosis. The study involved 34- patients with cirrhosis of different etiologies...
HEALTH-PROMOTING EFFECTS OF MANUKA HONEY
Honey properties are determined by the level of methylglyoxal (antimicrobial substance) from 30 to 550 in the case of MGO method or from 5 to 20 by UMF method. Previous studies have shown that high levels of methylglyoxa...
EXPOSURE TO TICKS AND PREVENTIVE ACTIONS IN THE SCOPE OF LYME DISEASE AMONG YOUNG PEOPLE FROM THE NORTHERN PART OF LUBLIN PROVINCE (EASTERN POLAND)
Background. The ticks are the main vector of pathogens of infectious diseases both for people and animals. At present, tick-borne infections spread in the entire Europe. Lyme disease domi¬nates among diseases spreading t...
EPIDEMIOLOGICAL SITUATION OF LYME BORRELIOSIS IN THE POLISH-BELARUSIAN BORDERLAND IN THE YEARS 2012-2016 (PODLASIE PROVINCE AND GRODNO REGION)
Lyme borreliosis (LB) is the most common tick-borne disease in Europe and the number of reported cases is constantly rising. An increase in morbidity can be observed both in Poland and Belarus; however, the recorded rate...